Chronic ocular diseases can seriously impact the eyes and could potentially result in
blindness or serious vision loss. According to the most recent data from the WHO, there are …

Ocular drug delivery has seen several advances in the past few decades, with respect to
new drugs, improved formulations, targeted delivery, as well as exploration of new routes of …

Ocular drug delivery has constantly challenged ophthalmologists and drug delivery
scientists due to various anatomical and physiological barriers. Static and dynamic ocular …

Numerous novel nano-based ocular drug delivery systems have been developed to
overcome the limitations of conventional drug delivery systems, which have demonstrated …

Ocular drug delivery has been widely recognized as an attractive route for drug
administration for cures of ocular diseases. Overall, designing an effective therapy to cure …

Purpose Due to the inimitable anatomical structure of the eyeball and various physiological
barriers, conventional ocular local administration is often complicated by apparent …

Successful treatment of pathologies affecting eye depends on inherent activity of the drug, its
ability to cross several ocular barriers in order to reach biophase and most importantly its …

The complex drug delivery barrier in the eye reduces the bioavailability of many drugs,
resulting in poor therapeutic effects. It is necessary to investigate new drugs through …

The major challenge faced by today's pharmacologist and formulation scientist is ocular
drug delivery. Topical eye drop is the most convenient and patient compliant route of drug …

Vitreoretinal diseases are refractory to both topical and systemic pharmacological
approaches because of specific environment of the eye. That is, the cornea, the sclera …